Liposome Drug Delivery Will Generate Booming Growth Opportunities to 2031| Novartis, Luye Pharma Group, Ipsen Pharma, Astellas Pharma, Inc., etc.

The global Liposome Drug Delivery Market was valued at US$ 4.2 billion in 2021 and is expected to reach US$ 11.5 billion by 2031. The market is expected to register a CAGR of 8.3% from 2023 to 2031. Liposome-based drug